Cytokine Bioscience is a company that offers a new biological medicinal product for the treatment of osteoarthritis symptoms. The product is called HAS2021 and it offers a non-surgical treatment option to reduce pain and improve function. It has been shown to reduce pain faster, regenerate faster and reduce inflammatory reactions. It is the first drug of its type on the EU market and it is ready and easy to use off the shelf for 2 years.
This can significantly increase sales, result in better cooperation with suppliers, and boost revenue.